Cutting down on repeated nuclear and molecular imaging scans due to poor quality images could save about $1.32 billion over the next 10 years, according to the Society of Nuclear Medicine.
Cutting down on repeated nuclear and molecular imaging scans due to poor quality images could save about $1.32 billion over the next 10 years, according to a report from the Society of Nuclear Medicine.
Four percent to 7 percent of these procedures are repeated because of poor imaging, SNM said, and Medicare spends about $132 million in avoidable scans each year.
“Having to repeat a nuclear or molecular imaging scan because of the poor quality of the original image is something that shouldn’t happen and something that can be fixed,” Ann Marie Alessi, BS, CNMT, NCT, RT(N), president of SNM’s Technologist Section, said in a statement.
Ensuring that technologists have the appropriate training and education would help reduce most of these repeated scans, Alessi said. The SNM is advocating for the passage of the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging (CARE) bill before Congress. The measure would establish minimum education and certification standards for those who perform nuclear medicine and molecular imaging procedures.
Thirty states and the District of Columbia have certification or licensure provisions for nuclear medicine and molecular imaging technologists requiring they be certified a national credentialing organization, according to SNM.
“With new technologies upon us every year," Alessi said, "it’s critical that nuclear medicine and molecular imaging technologists are up to date on the techniques needed to appropriately perform the imaging scans."
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.